Professor Stewart Harris holds the Diabetes Canada Chair in Diabetes Management. His research career has focused on identifying and closing the care gap for disadvantaged Canadians with diabetes. His pioneering work carved new understandings of the pathophysiology and epidemiology of diabetes in Canada’s Indigenous Peoples. His research has also had widespread impacts on therapeutic development and management in primary care. His other areas of interest include the epidemiology of hypoglycemia and pragmatic clinical trials. He has received numerous awards for his work including being appointed to the Order of Canada in 2015 for his contributions to developing diabetes prevention strategies in Indigenous communities and other vulnerable populations. He has published over 300 articles. Dr. Harris’s internationally recognized career reflects a passionate commitment to medicine, science, and mentorship. Disclosures Grants/ Research Support: AstraZeneca, Eli Lilly, Juvenile Diabetes Research Foundation (JDRF), Novo Nordisk, Sanofi Honoraria/Consulting: Abbott, AstraZeneca, Bayer Inc., Dexcom, Eli Lilly, HLS Therapeutics, Janssen, Novo Nordisk, Sanofi Ad Board Member: Abbott, AstraZeneca, Bayer Inc., Dexcom, Eli Lilly, HLS Therapeutics, Janssen, Novo Nordisk, Sanofi Clinical Trial Participation: Abbott, Applied Therapeutics Inc., Novo Nordisk, Sanofi